Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
55.50    -0.50 (-0.89%)
Bid:
55.00
Ask:
56.00
Spread: 1.00 (1.818%)
Market Cap: £8.45m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Trading Update

18 Jul 2016 07:01

RNS Number : 3909E
Transense Technologies PLC
18 July 2016
 

18 July 2016

Transense Technologies Plc

("Transense" or "the Company")

Trading Update

Transense Technologies Plc (AIM: TRT), the provider of sensor systems for the transportation and industrial markets, provides a trading update relating to the financial year ended 30 June 2016.

Trading update

The company reported that the sale of IntelliSaw to Emerson in October 2015, with the associated limited scope licensing of core Surface Acoustic Wave ("SAW") sensor technology, provided a strong signal to the industrial marketplace of the increasing maturity and value of this expertise. Progress towards commercialisation of SAW across several other applications has been steady throughout the second half of the year. This has become evident through the successful product launch by a major European customer in April 2016, and the post year-end signing of a licensing agreement in partnership with GE announced today. In the short term, SAW revenue generation is not a key value driver, however the board are pleased to note that sales for the full year did finish broadly in line with expectations.

The rate of revenue growth in Translogik continues to be held back by difficult market conditions in the mining sector. Several live trials are in progress and demonstrating good results, but decision making timescales continue to be elongated by financial and other constraints. Meanwhile, there has been an upturn in the rate of sales of tyre probe products in the second half of the year, which is encouraging.

Overall, trading results for the year ended 30 June 2016 are expected to be in line with the board's expectations as revised on the release of the interim results in March, with revenues of approximately £2M, and closing cash balances of £3.6M.

 

Capital structure

The board has taken advice on steps which may be taken to eliminate the accumulated deficit on reserves through a capital restructuring exercise and intends to bring proposals forward at the Annual General Meeting later this year.

 

 

For further information please visit www.transense.co.uk or contact:

 

Transense Technologies Plc

Graham Storey, Chief Executive

 

Tel: +44 (0) 1869 238380

 

finnCap

Ed Frisby, Giles Rolls (Corporate Finance)

Tony Quirke, Alice Lane (Corporate Broking)

 

Tel: +44 (0) 20 7220 0500

 

IFC Advisory

Tim Metcalfe, Graham Herring, Heather Armstrong

 

Tel: +44 (0) 20 3053 8671

 

 

 

About Transense Technologies

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. Transense's Surface Acoustic Wave (SAW), wireless, battery-less, sensor systems offer significant advantages over legacy wireless sensor systems. Transense is targeting the transport and mining industries, and the global torque, temperature and pressure sensing markets, via its trading divisions, Translogik and SAWSense.

Transense's shares are admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT).

www.transense.co.uk

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKODNFBKDPOD
Date   Source Headline
20th Nov 20243:22 pmRNSHolding(s) in Company
30th Oct 20245:27 pmRNSDirector/PDMR Shareholding - acquisition of shares
21st Oct 20247:00 amRNSPosting of Annual Report & Notice of AGM
10th Oct 202411:05 amRNSDirector/PDMR Shareholding - acquisition of shares
27th Sep 202411:28 amRNSHolding(s) in Company
26th Sep 202410:42 amRNSHolding(s) in Company
23rd Sep 20247:00 amRNSFinal Results & Investor Presentation
18th Sep 20247:00 amRNSTransense Selected for £11 Million EV R&D Project
3rd Sep 20247:00 amRNSNotice of Annual Results & Investor Presentation
1st Aug 202410:35 amRNSDirector/PDMR shareholding – acquisition of shares
17th Jul 20247:00 amRNSGrant of Share Options
16th Jul 20247:00 amRNSTrading Update
26th Jun 20247:00 amRNSAppointment of Independent Non-Executive Director
18th Jun 20247:00 amRNSDirector/PDMR Shareholding – acquisition of shares
30th May 20245:25 pmRNSHolding(s) in Company
30th May 20245:20 pmRNSHolding(s) in Company
24th May 20247:00 amRNSHolding(s) in Company
13th May 20247:00 amRNSUpcoming Investor & Analyst Events
10th May 20244:50 pmRNSHolding(s) in Company
1st May 20247:00 amRNSDirector/PDMR - Acquisition of Shares
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTRT joins £37.8m LANDOne project with Airbus & ATI
17th Apr 20246:00 pmRNSTransaction in Own Shares & TVR
15th Apr 20242:51 pmRNSTransaction in Own Shares & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 20233:23 pmRNSHolding(s) in Company
3rd Oct 20236:00 pmRNSHolding(s) in Company
28th Sep 20235:22 pmRNSHolding(s) in Company
27th Sep 20233:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.